Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00420888
Status:
COMPLETED
Last Update Posted:
2015-07-22
First Post:
2007-01-09
Brief Title:
ABR-217620Naptumomab Estafenatox With Interferon-alpha IFN-alpha Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
Sponsor:
Active Biotech AB
Organization:
Active Biotech AB
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Renal Cell Carcinoma |
Keywords: